Document is current
Any future updates will be listed below
-
Authors
- License Information
-
More Information
Article History
Received: 7 December 2024
Accepted: 13 January 2025
First Online: 11 March 2025
Declarations
:
: Not applicable.
: Not applicable.
: PMB was: Chief Investigator of the ENOS and RIGHT-2 trials of GTN, Chair of the REMEDY-1 trial steering committee and is a member of the Scientific Advisory Group for REMEDY-2 (he has received honoraria from DiaMedica Therapeutics Inc. for these roles).
